New Zealand markets closed

SunLink Health Systems, Inc. (SSY)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.7110+0.0094 (+1.34%)
At close: 03:58PM EDT
0.7010 -0.01 (-1.41%)
After hours: 07:15PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.7016
Open0.7000
Bid0.0000 x 900
Ask0.0000 x 1200
Day's range0.7000 - 0.7501
52-week range0.5300 - 1.0500
Volume77,904
Avg. volume30,666
Market cap5.006M
Beta (5Y monthly)1.39
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date29 Sept 1989
1y target estN/A
  • Business Wire

    SunLink Health Systems, Inc. Announces Sale of Trace Extended Care & Rehab

    ATLANTA, June 03, 2024--SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., has completed the sale of its Trace Extended Care & Rehab senior care facility and related real estate in Houston, Mississippi for approximately $7,100,000. The company said the net proceeds of approximately $6,500,000 will be retained for working capital and general corporate purposes. The company expects to recognize a pre-tax gain on the

  • Business Wire

    SunLink Health Systems, Inc. Announces Fiscal 2024 Third Quarter Results

    ATLANTA, May 15, 2024--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for its third fiscal quarter ended March 31, 2024 compared to a loss from continuing operations of $453,000 (or a loss of $0.06 per fully diluted share) for the third fiscal quarter ended March 31, 2023.

  • Business Wire

    SunLink Health Systems, Inc. Announces Fiscal 2024 Second Quarter Results

    ATLANTA, February 13, 2024--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for its second fiscal quarter ended December 31, 2023 compared to earnings from continuing operations of $2,277,000 (or $0.32 per fully diluted share) for the second fiscal quarter ended December 31, 2022.